tm logo

Monitor this mark

View On USPTO

ANELLOME
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 21 Aug 2024

Last Applicant/ Owned by

Ring Therapeutics, Inc.

140 First Street

Cambridge

MA

02141

Serial Number

97462059 filed on 16th Jun 2022

Registration Number

N/A

Correspondent Address

Christina M. Licursi

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

BOSTON, MA 02210

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ANELLOME

Diagnostic reagents for scientific or research use Encapsulated nucleic acid agents for medical use

Classification Information

Class [005]
Pharmaceutical Products

Encapsulated nucleic acid agents for medical use

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products

Diagnostic reagents for scientific or research use

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97462059

Mark Type

No Service/Collective Mark

Attorney Docket Number

No V03222000001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
21st Aug 2024SOU EXTENSION 3 FILED
21st Aug 2024SOU EXTENSION 3 GRANTED
21st Aug 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Aug 2024SOU TEAS EXTENSION RECEIVED
22nd Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Feb 2024SOU EXTENSION 2 GRANTED
21st Feb 2024SOU EXTENSION 2 FILED
21st Feb 2024SOU TEAS EXTENSION RECEIVED
26th Dec 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
26th Dec 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED